CN101953781B - 盐酸伊立替康溶液型注射剂及其制备方法 - Google Patents
盐酸伊立替康溶液型注射剂及其制备方法 Download PDFInfo
- Publication number
- CN101953781B CN101953781B CN2009100551003A CN200910055100A CN101953781B CN 101953781 B CN101953781 B CN 101953781B CN 2009100551003 A CN2009100551003 A CN 2009100551003A CN 200910055100 A CN200910055100 A CN 200910055100A CN 101953781 B CN101953781 B CN 101953781B
- Authority
- CN
- China
- Prior art keywords
- salt
- irinotecan hydrochloride
- acid
- injection
- type injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
指标 | 0天 | 3个月 | 6个月 | 9个月 | 12个月 |
含量% | 96.71 | 96.24 | 96.31 | 96.05 | 95.88 |
单个最大/总杂质% | 0.08/0.30 | 0.09/0.30 | 0.10/0.35 | 0.13/0.40 | 0.14/0.45 |
指标 | 0天 | 3个月 | 6个月 | 9个月 | 12个月 |
含量% | 99.14 | 99.43 | 99.02 | 99.19 | 98.78 |
单个最大/总杂质% | 0.06/0.19 | 0.06/0.20 | 0.07/0.21 | 0.07/0.24 | 0.08/0.28 |
指标 | 0天 | 3个月 | 6个月 | 9个月 | 12个月 |
含量% | 98.14 | 98.32 | 97.96 | 98.21 | 98.07 |
单个最大/总杂质% | 0.08/0.27 | 0.12/0.30 | 0.14/0.38 | 0.15/0.42 | 0.20/0.47 |
指标 | 0天 | 3个月 | 6个月 | 9个月 | 12个月 |
含量% | 100.45 | 100.78 | 100.21 | 99.89 | 100.33 |
单个最大/总杂质% | 0.08/0.27 | 0.08/0.33 | 0.08/0.41 | 0.10/0.51 | 0.11/0.58 |
指标 | 0天 | 3个月 | 6个月 | 9个月 | 12个月 |
含量% | 98.04 | 97.43 | 97.86 | 98.13 | 97.60 |
单个最大/总杂质% | 0.10/0.47 | 0.13/0.50 | 0.15/0.62 | 0.18/0.70 | 0.19/0.74 |
指标 | 0天 | 3个月 | 6个月 | 9个月 | 12个月 |
含量% | 98.71 | 98.46 | 97.92 | 97.13 | 96.59 |
单个最大/总杂质% | 0.09/0.31 | 0.17/0.46 | 0.22/0.94 | 0.34/1.35 | 0.67/2.74 |
指标 | 0天 | 3个月 | 6个月 | 9个月 | 12个月 |
含量% | 98.62 | 97.61 | 97.16 | 96.54 | 95.68 |
单个最大/总杂质% | 0.12/0.41 | 0.27/0.64 | 0.45/1.25 | 0.59/1.97 | 0.82/2.89 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100551003A CN101953781B (zh) | 2009-07-21 | 2009-07-21 | 盐酸伊立替康溶液型注射剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100551003A CN101953781B (zh) | 2009-07-21 | 2009-07-21 | 盐酸伊立替康溶液型注射剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101953781A CN101953781A (zh) | 2011-01-26 |
CN101953781B true CN101953781B (zh) | 2012-06-27 |
Family
ID=43481541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100551003A Active CN101953781B (zh) | 2009-07-21 | 2009-07-21 | 盐酸伊立替康溶液型注射剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101953781B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102670500B (zh) * | 2012-06-14 | 2014-05-21 | 南京臣功制药股份有限公司 | 一种盐酸伊立替康注射液及其制备方法 |
CN102697720B (zh) * | 2012-06-29 | 2014-01-15 | 海南灵康制药有限公司 | 盐酸伊立替康脂质纳米粒注射剂 |
CN102824345B (zh) * | 2012-09-20 | 2014-03-26 | 江苏奥赛康药业股份有限公司 | 一种盐酸伊立替康组合物及其制备方法 |
CN102885765B (zh) * | 2012-10-25 | 2013-11-06 | 哈药集团生物工程有限公司 | 一种盐酸伊立替康注射液及其制备方法 |
CN105434343A (zh) * | 2016-01-06 | 2016-03-30 | 青岛辰达生物科技有限公司 | 一种盐酸伊立替康注射液及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229118A (zh) * | 2007-11-22 | 2008-07-30 | 山东蓝金生物工程有限公司 | 含拓扑酶抑制剂的温控缓释注射剂及其制备方法 |
-
2009
- 2009-07-21 CN CN2009100551003A patent/CN101953781B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229118A (zh) * | 2007-11-22 | 2008-07-30 | 山东蓝金生物工程有限公司 | 含拓扑酶抑制剂的温控缓释注射剂及其制备方法 |
Non-Patent Citations (3)
Title |
---|
张学军等.注射用盐酸托泊替康与常用注射液的配伍稳定性.《西北药学杂志》.2009,第24卷(第1期), * |
戴建国等.注射用盐酸拓扑替康的质量分析方法研究.《中国新药杂志》.2003,第12卷(第8期), * |
狄斌等.抗癌新药伊立替康有关物质的研究.《中国药科大学学报》.1999,第30卷(第3期), * |
Also Published As
Publication number | Publication date |
---|---|
CN101953781A (zh) | 2011-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101953781B (zh) | 盐酸伊立替康溶液型注射剂及其制备方法 | |
EP2525796B1 (en) | Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease | |
CN101732246A (zh) | 莫西沙星水溶液型注射剂 | |
KR20210027410A (ko) | 무수 싸이오황산나트륨의 제형 | |
CN108992400B (zh) | 一种含有盐酸伊立替康的药物组合物及其制备方法 | |
CN105434373A (zh) | 一种注射用奥拉西坦冻干制剂及其制备方法 | |
JP2020125359A (ja) | ペメトレキセドまたはその薬剤学的に許容可能な塩を含有する安定化された薬学組成物 | |
CN101575330B (zh) | 伏立康唑广谱抗真菌药物化合物、其组合物及用途 | |
CN103989630A (zh) | 盐酸莫西沙星氯化钠注射液及其制备方法 | |
CN102302462B (zh) | 一种盐酸吉西他滨冻干制剂 | |
CN104414977A (zh) | 一种注射用青蒿琥酯和l-精氨酸组合物及其制备方法 | |
CN102784382A (zh) | 一种阿加曲班药物组合物及其制备方法和应用 | |
CN102617584B (zh) | 一种盐酸伊立替康化合物及其药物组合物 | |
CN104784113B (zh) | 一种含有利奈唑胺的组合物及其制备方法 | |
CN100406021C (zh) | 灯盏花乙素注射制剂及其制备方法 | |
CN103845295A (zh) | 一种注射用帕洛诺司琼制剂及其制备方法 | |
CN101007004A (zh) | 安全稳定的帕洛诺司琼注射液 | |
CN102757471B (zh) | 一种新活性三磷酸胞苷二钠化合物及其药物组合物 | |
CN103919779B (zh) | 一种含有莫西沙星的药物组合物 | |
CN103655460B (zh) | 一种含氨曲南的注射用药物组合物及其制备方法和用途 | |
CN101292985A (zh) | 乳酸左氧氟沙星冻干粉针剂及其制备方法 | |
US20110207760A1 (en) | Sn-38 compositions | |
CN103432086A (zh) | 一种注射用培美曲塞二钠冻干粉针剂及其制备方法 | |
CN104829653B (zh) | 一种奥沙利铂水合物晶体及其冻干粉针剂 | |
CN1321997C (zh) | 一种稳定的噻丁啶喹啉羧酸盐在制备抗感染药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: SHANGHAI XIDI PHARMACEUTICAL CO., LTD. Owner name: SHANGHAI XIDI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: DISAINO MEDICINE DEVELOPMENT CO., LTD, SHANGHAI Effective date: 20110218 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 NO. 1479, ZHANGHENG ROAD, ZHANGJIANG HIGH-TECH. PARK, PUDONG NEW DISTRICT, SHANGHAI TO: 201203 BUILDING 9, NO. 1999, ZHANGHENG ROAD, ZHANGJIANG HIGH-TECH. PARK, PUDONG NEW DISTRICT, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110218 Address after: 201203, building 1999, No. 9 Zhang Heng Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Applicant after: Shanghai Xidi Pharmaceutical Co., Ltd. Address before: 201203 Zhang Heng road Shanghai, Pudong New Area Zhangjiang hi tech Park No. 1479 Applicant before: Disaino Medicine Development Co., Ltd, Shanghai Co-applicant before: Shanghai Xidi Pharmaceutical Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANGHAI CHUANGNUO PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SHANGHAI XIDI PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 201203, building 1999, No. 9 Zhang Heng Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee after: Shanghai Chuangnuo Pharmaceutical Co., Ltd. Address before: 201203, building 1999, No. 9 Zhang Heng Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee before: Shanghai Xidi Pharmaceutical Co., Ltd. |